The hypercalcemia of various granulomatoses is caused by endogenous 1,25-dihydroxyvitamin D [1,25-(OH) 2 D 3 ] overproduction by disease-activated macrophages. The inability of 1,25(OH) 2 D 3 to suppress its synthesis in macrophages contrasts with the tight control of its production in macrophage precursors, peripheral blood monocytes (PBM). We examined whether 1,25(OH) 2 D 3 resistance develops as PBM differentiate to macrophages or with macrophage activation. Normal human pulmonary alveolar macrophages (PAM) are less sensitive to 1,25(OH) 2 D 3 than PBM, despite similar vitamin D receptor content; however, both PBM and PAM respond to exogenous 1,25- Under normal physiological circumstances, 1,25(OH) 2 D 3 is synthesized almost exclusively in the kidney. The renal 1␣-hydroxylation of 25(OH)D 3 is catalyzed by a cytochrome P450-linked mixed function oxidase located in the mitochondria of the proximal tubules (3). Renal 1␣-hydroxylase activity is under stringent regulation by serum levels of parathyroid hormone, calcium, phosphorus and 1,25-(OH) 2 D 3 itself (3), so that serum 1,25(OH) 2 D 3 levels remain within the normal range even in cases of vitamin D intoxication in which circulating 25OHD 3 levels increase 70-fold above normal (4). In contrast, in sarcoidosis and tuberculosis, macrophage 1,25(OH) 2 D 3 synthesis correlates with 25OHD 3 levels (5) and the degree of the inflammatory response in the host (6), and 1,25(OH) 2 D 3 overproduction occurs despite severe hypercalcemia, suppressed PTH levels, and supranormal concentrations of 1,25(OH) 2 D 3 (7-9). These observations suggested that nonrenal 1␣-hydroxylases do not respond to the modulators of the renal enzyme. In fact, studies in vitro using sarcoid (6, 10) or cytokine activated macrophages (11) demonstrated that the 1␣-hydroxylation reaction is relatively immune to stimulation by calcium, PTH, or to feedback inhibition by 1,25(OH) 2 D 3 . The resistance of activated macrophages to 1,25(OH) 2 D 3 inhibition of its own production contrasts markedly with the high sensitivity to 1,25(OH) 2 D 3 of peripheral monocytes, the precursors of tissue macrophages. Similar to the renal enzyme, monocyte 1␣-hydroxylase activity is profoundly suppressed by physiological concentrations of 1,25(OH) 2 D 3 in vitro (12), and in vivo as demonstrated in peripheral monocytes from hemodialysis patients undergoing 1,25(OH) 2 D 3 replacement therapy (13). In order to characterize the cause of this discrepancy, we examined the mechanisms involved in 1,25(OH) 2 D 3 control of its synthesis in normal monocytes, and whether the response to the sterol in cells of the monocyte-macrophage lineage decreases as monocytes differentiate to tissue macrophages or as a result of macrophage activation.
Under normal physiological circumstances, 1,25(OH) 2 D 3 is synthesized almost exclusively in the kidney. The renal 1␣-hydroxylation of 25(OH)D 3 is catalyzed by a cytochrome P450-linked mixed function oxidase located in the mitochondria of the proximal tubules (3) . Renal 1␣-hydroxylase activity is under stringent regulation by serum levels of parathyroid hormone, calcium, phosphorus and 1,25-(OH) 2 D 3 itself (3), so that serum 1,25(OH) 2 D 3 levels remain within the normal range even in cases of vitamin D intoxication in which circulating 25OHD 3 levels increase 70-fold above normal (4) . In contrast, in sarcoidosis and tuberculosis, macrophage 1,25(OH) 2 D 3 synthesis correlates with 25OHD 3 levels (5) and the degree of the inflammatory response in the host (6) , and 1,25(OH) 2 D 3 overproduction occurs despite severe hypercalcemia, suppressed PTH levels, and supranormal concentrations of 1,25(OH) 2 D 3 (7) (8) (9) . These observations suggested that nonrenal 1␣-hydroxylases do not respond to the modulators of the renal enzyme. In fact, studies in vitro using sarcoid (6, 10) or cytokine activated macrophages (11) demonstrated that the 1␣-hydroxylation reaction is relatively immune to stimulation by calcium, PTH, or to feedback inhibition by 1,25(OH) 2 D 3 . The resistance of activated macrophages to 1,25(OH) 2 D 3 inhibition of its own production contrasts markedly with the high sensitivity to 1,25(OH) 2 D 3 of peripheral monocytes, the precursors of tissue macrophages. Similar to the renal enzyme, monocyte 1␣-hydroxylase activity is profoundly suppressed by physiological concentrations of 1,25(OH) 2 D 3 in vitro (12) , and in vivo as demonstrated in peripheral monocytes from hemodialysis patients undergoing 1,25(OH) 2 D 3 replacement therapy (13) . In order to characterize the cause of this discrepancy, we examined the mechanisms involved in 1,25(OH) 2 D 3 control of its synthesis in normal monocytes, and whether the response to the sterol in cells of the monocyte-macrophage lineage decreases as monocytes differentiate to tissue macrophages or as a result of macrophage activation.
An alternative mechanism for 1,25-(OH) 2 D 3 to control its net production, and therefore its plasma levels in humans, is to increase its metabolic clearance rate (14) through the enhancement of 24-hydroxylase activity, the enzyme responsible for 1,25(OH) 2 D 3 inactivation in mammals (2, 3) . 1,25(OH) 2 D 3 degradation occurs mainly in kidney and intestine (15) (16) (17) , where the sterol induces the expression of 24-hydroxylase through a typical steroid-like mechanism (18, 19) . 1,25(OH) 2 D 3 binds its intracellular vitamin D receptor (VDR), and the 1,25(OH) 2 D 3 -VDR complex interacts with additional nuclear transcription factors, and with specific vitamin D responsive elements in the promoter region of the 24-hydroxylase gene enhancing the rate of transcription (20) . A discrepancy similar to that described for 1,25(OH) 2 D 3 control of its synthesis also exists between normal PBM and disease activated macrophages in 1,25(OH) 2 D 3 -induction of its degradation. Early studies utilizing sarcoid PAM (10, 11) or cytokine activated PAM (21) , before the cloning of the human 24-hydroxylase, did not demonstrate induction of 24-hydroxylase activity even in response to concentrations of exogenous 1,25-(OH) 2 D 3 400 times above normal (10) . Interestingly, VDR content was not reduced in activated macrophages (22) . In contrast, in normal monocytes, physiological concentrations of 1,25-(OH) 2 D 3 induce 25OHD 3 (12, 23 ) and 1,25-(OH) 2 D 3 degradation (24) . The actual contribution of the C24-oxidation pathway in both processes in monocytes, however, has not been evaluated. It is possible that 1,25-(OH) 2 D 3 induction of its degradation in human monocytemacrophages does not involve C24-hydroxylation. Alternatively, 1,25-(OH) 2 D 3 -mediated transcriptional activation of the 24-hydroxylase gene may be impaired along monocytic differentiation to macrophages or as a direct result of macrophage activation.
To identify the mechanisms mediating 1,25(OH) 2 D 3 resistance, first, we assessed the involvement of rapid (nongenomic) and/or steroid-like (genomic) mechanisms in 1,25(OH) 2 D 3 control of its production in PBM. Next, we examined the role of differentiation by comparing the response to 1,25(OH) 2 D 3 in the inhibition of its synthesis as well as in the induction of catabolism between resting peripheral monocytes and pulmonary alveolar macrophages from normal adults. We present evidence that the human monocytic cell line THP-1 constitutes a proper model of tissue macrophage. Finally, we examined the effects of activation of normal monocytes and THP-1 cells with the cytokine ␥-IFN on 1,25(OH) 2 D 3 modulation of the activity of 1␣-and 24-hydroxylases, and in 1,25(OH) 2 D 3 -mediated induction of 24-hydroxylase gene transcription.
We demonstrate the existence of potent antagonistic effects of ␥-IFN not only on 1,25(OH) 2 D 3 control of the activities of 1␣-and 24-hydroxylases, but on 1,25(OH) 2 D 3 -induction of 24-hydroxylase mRNA levels. The latter is not the result of a decreased half life of 24-hydroxylase mRNA, suggesting that ␥-IFN impairs 1,25(OH) 2 D 3 transactivating function in normal monocytes and in THP-1 cells leading to vitamin D resistance. 25-hydroxy[26(27) 
Materials and Methods Materials

Cell culture
Peripheral blood mononuclear cells were isolated from normal volunteers using a Ficoll-Paque gradient (Pharmacia LKB Biotechnology, Piscataway, NJ) and processed as previously described (12, 23) . Briefly, cells were plated in six-well plates at a concentration of 10 7 cells/well in 1 mL RPMI 1640 medium containing 1% fatty acid free bovine serum albumin (BSA). After an 18 h incubation at 37 C in humidified 95% air, 5% CO 2 , nonadherent cells and medium were removed. More than 95% of these adherent cells stained positively for ␣-naphthyl esterase, a specific marker for cells of the monocyte-macrophage lineage (25) . The adherent cell population was used in all studies.
Human alveolar macrophages were isolated from healthy adult volunteers by saline bronchoalveolar lavage using a protocol approved by the Human Study Committee at Washington University Medical Center, as previously described (26, 27) . Macrophages were plated in 1 mL of Hank's balanced salt solution at a concentration of 10 6 cells per well and incubated for 1 h at 37 C to allow attachment. The medium was then replaced with 1 mL RPMI 1640 containing 1% fatty acid free BSA, and cells were incubated at 37 C in humidified 95% air, 5% CO 2 for 18 h before use.
The human monocytic cell line THP-1 (kindly provided by Dr. Beth Lee, Renal Division, Washington University Medical Center, St. Louis, MO) was grown in suspension in RPMI 1640 containing 10% fetal bovine serum (FBS) and induced to acquire a macrophage phenotype (28) by exposure to 160 nmol/L phorbol 12-myristate 13-acetate (TPA) (Sigma, St. Louis, MO) for 24 h in six-well plates, at a concentration of 2 ϫ 10 6 cells/well. The medium was then exchanged for 1 mL RPMI 1640 containing 1% fatty acid free BSA and the adherent, phorbol differentiated THP-1 cells (dTHP-1 cells) were incubated at 37 C in humidified 95% air, 5% CO 2 for 18 h before use.
Time course for the effects of 1,25-(OH) 2 D 3 on vitamin D metabolism in normal human monocytes
Normal peripheral blood monocytes plated in RPMI 1640 containing 1% fatty acid free BSA were exposed to 0 (Control) or 0.24 nmol/L 1,25-(OH) 2 D 3 for 0.5, 1, 2, 3, and 4 h. Medium was removed, and cells were washed once with PBS and twice with incubation medium (RPMI 1640 containing 0.1% fatty acid free BSA) to remove exogenous 1,25-(OH) 2 (29, 30) . At the end of the incubation, 1 mL acetonitrile and 0.5 mL of 0.4 mol/L K 2 HPO 4 (pH ϭ 10.6) were added, samples were centrifuged at 2,500g for 15 min, and subsequently re-extracted using C-18 cartridges. To further characterize the polar metabolites, we performed normal phase high performance liquid chromatography (HPLC) on the acetonitrile fraction using 2.7% isopropanol in methylene chloride as the mobile phase and a flow rate of 2 mL/min. The retention times of 24,25(OH) 2 16 .0, and 9.9, respectively. A 2-min methanol strip of the column followed the elution of the 1,24,25(OH) 2 D 3 peak. HPLC fractions of tritiated metabolites eluting with nonradioactive standards and with methanol were collected and counted for tritium. Results were compared to control samples run in parallel but not subjected to NaIO 4 treatment.
were washed twice with PBS and once with incubation medium. The rate of conversion of tritiated 25OHD 3 to polar metabolites was measured in triplicate for each experimental condition, as described (12, 23 24 -hydroxylase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels using the ribonuclease protection assay described previously (23) . Briefly, total RNA was dissolved in 4 L of diethyl pyrocarbonate water and mixed with 26 L hybridization buffer (80% formamide, 50 mmol/L PIPES, pH ϭ 6.4, 400 mnol/L NaCl, 1 mmol/L EDTA) containing 32 P labeled riboprobes for human 24-hydroxylase and glyceraldehyde-3-phosphate dehydrogenase. After hybridization at 45 C for 16 h, samples were mixed with 150 L ribonuclease digestion mixture containing 2 g ribonuclease T1 in 10 mmol/L Tris-HCl, pH 5.0, 300 mmol/L NaCl, 5 mmol/L EDTA, and incubated for 15 min at 37 C. Proteinase K (50 g) and 20 L of 5% sodium dodecyl sulfate were then added, and the samples were incubated for 15 additional minutes. Following phenolchloroform extraction and ethanol precipitation, samples were resolved on a 5% polyacrilamide gel. Bands in the dried gel were quantified by scanning densitometry after a 48 hexposure using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Riboprobes.. The human 24-hydroxylase template is the BamHI restriction fragment, bases 1657 to 1999 of the human 24-hydroxylase complementary (c)DNA (kindly provided by Dr H. DeLuca, University of Wisconsin, Madison, WI) subcloned into Bluescript KS (Stratagen, La Jolla, CA). The template for human GAPDH was purchased from Ambion (Austin, TX). For both templates, radiolabeled antisense riboprobes were produced using RNA polymerase T7. The size of the protected fragments was 342 bp for the human 24-hydroxylase and 150 for the human GAPDH. 2 2 D 3 tested, as described for PBM. To quantitate mRNA levels, total RNA was prepared from three individual wells of cells for each experimental condition and assayed for 24-hydroxylase and GAPDH mRNA levels using the ribonuclease protection assay described above.
1,25-(OH)
Vitamin D receptor content
To assess VDR content, PBM, PAM, and dTHP-1 cells were incubated with 0.26 nmol/L [ 3 H]-1,25-(OH) 2 D 3 for 1 h at 37 C, with (nonspecific binding) or without 125 nmol/L radioinert 1,25-(OH) 2 D 3 . Maximal specific 1,25-(OH) 2 D 3 binding to the VDR was measured as previously described (23) . Briefly, cells were rinsed with PBS containing 5 mg/ml albumin, placed on ice, and sonicated for 30 sec in 2 mL TEDK buffer. Free 1,25-(OH) 2 D 3 was separated from the bound sterol using dextrancharcoal, and tritium was counted in the supernatant.
Effect of ␥-IFN on 1,25-(OH) 2 D 3 synthesis in dTHP-1 cells
THP-1 cells were exposed to 160 nmol/L TPA in 10% FBS RPMI 1640 for 24 h. dTHP-1 cells were then washed twice with PBS and once with serum free RPMI 1640 containing 1% fatty acid free BSA, and incubated in RPMI 1640 containing 1% BSA and 0 or 2000 IU/mL ␥-IFN for 18 h. Cells were then washed and 1,25-(OH) 2 D 3 synthesis was measured as described for PBM. For Km and Vmax determinations, 1,25-(OH) 2 D 3 synthesis was measured in triplicate using four different concentrations of 25OHD 3 (from 5 to 300 nm). 1,25(OH) 2 D 3 synthesis was measured in triplicate for every substrate concentration; Km and Vmax were obtained from a linear regression analysis of the data using the double reciprocal plot of Lineweaver-Burk.
To assess whether the 1␣-hydroxylation of 25OHD 3 in dTHP-1 cells was mediated by a cytochrome P450-linked mixed function oxidase, or by nonenzymatic oxidation of 25OHD 3 by free radicals (generated through the activation of macrophages by ␥-IFN), dTHP-1 cells were incubated with 0 or 2000 IU/mL ␥-IFN for 18 h as indicated for Km and Vmax determinations. Cells were then washed, and the incubation medium was replaced by 0.1% BSA-RPMI 1640 containing 10 mol/L ketoconazole, a cytochrome P450 inhibitor, or the free radical scavengers N, NЈ-diphenylethylenediamine (10 mol/L) or ethylendiaminetetracetic acid (3 mmol/L). For each experimental condition, 1,25-(OH) 2 D 3 synthesis was measured in triplicate.
We assessed the identity of the putative 1,25(OH) 2 D 3 generated by THP-1 cells as follows: Nonadherent THP-1 cells were plated in eight tissue culture dishes (60 ϫ 15 mmol/L), at a concentration of 6 ϫ 10 6 cells in 3 ml 10% FBS RPMI 1640 containing 160 nmol/L TPA, and incubated at 37 C for 24 h. Medium was then removed and replaced with 3 mL fresh serum free RPMI 1640 containing 1% fatty acid free BSA. 1000 U/mL ␥-IFN were then added to four of the dishes. Control (untreated) and ␥-IFN-treated dishes were incubated at 37 C for 18 h. Medium was then removed and replaced with fresh RPMI 1640 containing 0.5% BSA. Substrate was 50 nmol/L radioinert 25OHD 3 in half of the control and ␥-IFN treated culture dishes and 12 nmol/L 3 H-25(OH)D 3 in the remnant half. Reactions were stopped by the addition of 3 mL acetonitrile after a 4 or 6 h incubation at 37 C. To quantitate recoveries, 1000 cpm 3 H-1,25(OH) 2 D 3 were then added to the culture dishes incubated with radioinert 25OHD 3 , and 100 ng radioinert 1,25(OH) 2 D 3 to those dishes in which radioactive substrate was used. Vitamin D metabolites were then extracted from all culture dishes using C18 cartridges according to Reinhardt et al. (31) and further purified by straight phase HPLC using methylene chloride: isopropanol (96:4) at a flow rate of 2 mL/min. Radioinert 24,25(OH) 2 D 3 and 1,25(OH) 2 D 3 standards (100 ng) were used to identify the retention times for both metabolites in control and ␥-IFN treated cultures dishes. One min fractions were collected and counted for tritium. The amount of putative 3 H-1,25(OH) 2 D 3 synthesized in 4 h was measured as described (12, 23) , and this rate of synthesis was used to estimate the expected concentration of putative 1,25(OH) 2 D 3 synthesized by dTHP-1 cells incubated with radioinert substrate. In these samples, the putative 1,25(OH) 2 D 3 fractions co-eluting with 1,25(OH) 2 D 3 standards (retention time: 11.3 min) in the first HPLC purification (methylenechloride:isopropanol) were then subjected to two additional HPLC purifications: a straight phase using hexane:isopropanol (88:12) at a flow rate of 1.8 mL/min (retention time for 1,25(OH) 2 D 3 : 9.15 min), and a reverse phase HPLC using methanol: water (87:13) at a flow rate of 2 mL/min (retention time for 1,25(OH) 2 
Effect of ␥-IFN on 1,25-(OH) 2 D 3 -actions in normal human monocytes
Peripheral monocytes from normal volunteers were exposed to 0 or 0.24 nmol/L 1,25-(OH) 2 D 3 in the presence of 0 or 2000 IU/mL ␥-IFN for 18 h at 37 C in serum-free (1% BSA) RPMI 1640. Cells were then washed, and 1,25-(OH) 2 D 3 synthesis was measured in cells incubated in RPMI 1640 containing 0.1% fatty acid free albumin as described above. Total mRNA was prepared from three individual wells of monocytes for each experimental condition and assayed for 24-hydroxylase and GAPDH mRNA levels as described. Determinations of 1␣-hydroxylase activity and mRNA levels were performed in triplicate.
Effect of ␥-IFN on the half life of 24-hydroxylase mRNA
dTHP-1 cells were exposed to 9.6 nmol/L 1,25-(OH) 2 D 3 , and 0 or 20 U/mL ␥-IFN. After an 18 h incubation, 5 g of the RNA polymerase II inhibitor actinomycin D were added to block further transcription. Total RNA from untreated and ␥-IFN treated cells was prepared at times of 0, and 1, 2, 4, or 6 h after the addition of actinomycin D. 24-hydroxylase, and GAPDH mRNA levels were quantitated by ribonuclease protection assay. Based on the single exponential decay of the 24-hydroxylase/ GAPDH ratio in untreated and ␥-IFN-treated dTHP-1 cells, the half life of 24-hydroxylase mRNA was calculated as ln 2/slope of the linear regression of ln (24-hydroxylase/GAPDH mRNA ratio) vs. time (h).
Statistics
Data are expressed as mean Ϯ sem. The symbol (n ϭ ) refers to the number of independent experiments performed. Statistical analysis was performed using one tailed unpaired nonparametric Mann-Whitney Two Sample Test or one way ANOVA for multiple comparisons. Paired t test was employed when comparing results before and after treatment in cells from the same individual.
Results
Mechanisms mediating 1,25(OH) 2 D 3 regulation of vitamin D metabolism in normal peripheral blood monocytes.
Because the resistance of activated macrophages to 1,25(OH) 2 D 3 -inhibition of its own synthesis is unrelated to changes in VDR content, we first examined whether the tight control by 1,25(OH) 2 D 3 of its own synthesis in normal monocytes involved rapid, nongenomic mechanisms instead of the most common steroid-like action mediated by the VDR. Figure 1 depicts the time course for the effects of physiological concentrations of 1,25-(OH) 2 D 3 (0.24 nmol/L) on vitamin D metabolism in peripheral monocytes. Both effects of the sterol, the suppression of 1,25-(OH) 2 D 3 synthesis and the induction of catabolic pathways, measured by the rate of synthesis of polar metabolites, were only evident after 2 h. In four independent experiments, the sterol was unable to reduce 1,25-(OH) 2 D 3 synthesis or to enhance the generation of polar metabolites by PBM in 10, 20, 40, or 60 min, even at a concentration of 1,25-(OH) 2 D 3 as high as 0.96 nmol/L (data not shown). However, because the 1␣-hydroxylase has not been purified to homogeneity or cloned, we could not confirm the actual involvement of genomic mechanisms in 1,25-(OH) 2 D 3 suppression of its own synthesis in PBM. We therefore focused on characterizing whether 1,25-(OH) 2 D 3 induction of its own catabolism in monocytes involved a genomic mechanism. Specifically, we examined the C24-hydroxylation pathway, the major catabolic pathway induced by 1,25(OH) 2 D 3 through a classical steroid-like mechanism in kidney and intestine in mammals (18, 19) . sis of polar metabolites depicted in Fig. 1 . To further confirm this correlation, we examined whether the polar metabolites were 24-hydroxylated by using the classical periodate cleavage reaction (30) and HPLC elution profiles. Polar metabolites synthesized from tritiated 25OHD 3 by untreated cells (controls) or by monocytes exposed to 0.24 nmol/L 1,25-(OH) 2 D 3 for 18 h were subjected to 8% NaIO 4 for 30 min at 0 -4 C and further HPLC-purified as described in Materials and Methods. NaIO 4 cleaves the side chain of cholecalciferols between adjacent hydroxyl groups, and because the 3 H-25OHD 3 used as substrate in these experiments was labeled at C26 and C27, both C24 or C26 hydroxylations would result in loss of radioactivity after periodate treatment. 25-26 dihydroxylated compounds, however, would only lose half of the tritium. Control experiments using tritiated 25OHD 3 and 1,25-(OH) 2 D 3 showed no degradation of these metabolites by NaIO 4 . In addition, NaIO 4 treatment had no effect on the 1,25-(OH) 2 D 3 produced by the cells, confirming its specificity of action for vitamin D metabolites containing diols. In three independent experiments, NaIO 4 treatment resulted in a total loss of radioactivity eluting with the polar metabolite fraction in 1,25-(OH) 2 .0 nmol/L), the induction of catabolic pathways was only 1.5-fold above control (2.1 Ϯ 1.7 fmol/g DNA/h) and did not reach statistical significance. Table 1 shows 24-hydroxylase:GAPDH mRNA levels in 1,25(OH) 2 D 3 -treated PAM. Similar to the induction of activity of enzymes involved in catabolic pathways, an exogenous 1,25-(OH) 2 D 3 concentration of 4.8 nmol/L and 18-h exposure to the sterol were required for PAM to increase 24-hydroxylase mRNA to detectable levels. The lower sensitivity to 1,25(OH) 2 D 3 of PAM was not caused by a decrease in VDR, as we found no difference in maximal specific binding of tritiated 1,25-(OH) 2 D 3 to the VDR between PBM and PAM (PBM: 0.65 Ϯ 0.1 fmol/g DNA, n ϭ 5; vs. PAM: 0.67 Ϯ 0.17, n ϭ 3).
Vitamin D metabolism and its regulation by 1,25(OH) 2 D 3 in the human monocytic cell line THP-1
We examined the human monocytic leukemia cell line THP-1 as a potential model of tissue macrophage. THP-1 cells differentiate toward a macrophage-like state by exposure to 160 nmol/L TPA for 24 h (28). Vitamin D metabolism was measured in phorbol differentiated THP-1 cells (dTHP-1) after an 18 h incubation in serum-free RPMI 1640 containing 1% fatty acid free albumin. Table 2 
Effects of ␥-IFN on 1,25(OH) 2 D 3 action
To assess the effects of macrophage-activation on the response to 1,25-(OH) 2 A potential post-transcriptional mechanism for ␥-IFN to reduce 1,25(OH) 2 D 3 induction of 24-hydroxylase mRNA levels would be to decrease the stability of 24-hydroxylase mRNA. To test this possibility, we measured the half life of 24-hydroxylase mRNA in untreated and ␥-IFN treated THP-1 cells. Fig. 7 (left panel) depicts the single exponential decays of 24-hydroxylase mRNA levels with time after blocking further transcription with the RNAse polymerase II inhibitor actinomycin D in ␥-IFN treated and untreated THP-1 cells. In two independent experiments, the estimated half life of 24-hydroxylase mRNA was 4.5 Ϯ 0.15 h in control cells and 4.9 Ϯ 1.3 h in ␥-IFN treated dTHP-1 cells. Clearly, ␥-IFN does not reduce 24-hydroxylase mRNA stability, as better illustrated in Fig. 7 (right panel) , when the 24-hydroxylase/ GAPDH mRNA ratio is plotted as percent of time 0. This suggests an antagonistic effect of the cytokine on 1,25(OH) 2 D 3 induction of 24-hydroxylase gene transcription.
Discussion
We have identified the mechanism responsible for the resistance of disease-activated macrophages to 1,25(OH) 2 D 3 , which causes supranormal serum 1,25(OH) 2 D 3 levels and hypercalcemia in various granulomatoses. The demonstration that the VDR content does not change with macrophage activation (22) suggests that 1,25-(OH) 2 D 3 inhibition of its own synthesis in cells of the monocyte-macrophage lineage may involve rapid, nongenomic mechanisms similar to the 1␣-hydroxylase of kidney cell cultures (34) . Time course experiments in normal PBM ruled out the involvement of rapid, nongenomic actions in 1,25-(OH) 2 D 3 control of monocytic 1␣-hydroxylase. 1,25-(OH) 2 D 3 suppression of its own synthesis required at least a 2-h exposure to physiological concentrations of the sterol. Even with concentrations of 1,25-(OH) 2 D 3 ten times above the normal range, no feedback inhibition of monocyte 1,25-(OH) 2 D 3 production was detected within the first hour. Although conclusive evidence of a genomic control by the sterol of its own synthesis awaits the cloning of the 1␣-hydroxylase, the recent demonstration of enhanced 1␣-hydroxylase activity and high serum 1,25-(OH) 2 D 3 levels in the VDR knockout mouse (35) supports our finding that 1,25-(OH) 2 D 3 suppression of its own synthesis may be a VDR mediated process.
The striking difference in the sensitivity to 1,25(OH) 2 D 3 inhibition of 1␣-hydroxylase activity between peripheral blood monocytes, the precursors of tissue macrophages, and activated macrophages raises the possibility that the cellular signaling pathways required by the sterol are lost either in the differentiation of peripheral monocytes to tissue macrophages or as a result of macrophage activation. To evaluate the contribution of monocyte differentiation in macrophageresistance to 1,25(OH) 2 D 3 , we examined 1,25(OH) 2 D 3 control of its synthesis in PAM obtained by bronchial lavage from healthy adult volunteers. PAM constitutively express 1␣-hydroxylase activity, and the rate of 1,25(OH) 2 D 3 production is similar to that of PBM. However, a concentration of (7), tuberculosis (8) , various granulomatoses (1), and rheumatoid arthritis (9) , or in vitro after exposure of normal PAM to ␥-IFN (10) or TNF␣ (21) . This led us to hypothesize cytokine-induced resistance to 1,25(OH) 2 D 3 in the control of its synthesis. To test this hypothesis, we overcame difficulties in obtaining human macrophages by examining the human monocytic cell line THP-1 as a potential model of tissue macrophage. THP-1 cells were chosen because of their ability to be induced to differentiate toward a macrophage-like state by exposure to phorbol esters (28) . Phorbol-differentiated THP-1 cells mimic more closely monocyte derived macrophages in the expression of oncogenes and membrane proteins than their more widely used counterparts, HL-60 or U937 cells (36) . We demonstrate that phorbol-differentiated THP-1 cells mimic normal PAM in the constitutive expression of 1␣-hydroxylase activity and in the 30 fold-increase in 1,25(OH) 2 (15) (16) (17) (18) (19) . In nearly all target tissues, 1,25-(OH) 2 D 3 induces 24-hydroxylase, the key enzyme in mammalian vitamin D catabolism (15) (16) (17) . Previous reports from our laboratory in normal monocytes have shown that physiological concentrations of exogenous 1,25-(OH) 2 D 3 induce vitamin D catabolism (12, 23 ) and 1,25-(OH) 2 D 3 degradation (24); however, the contribution of the C24-hydroxylation pathway in both processes has not been evaluated. The present studies demonstrate that 1,25-(OH) 2 D 3 induction of vitamin D catabolism also requires a 2-h exposure to the sterol and ongoing protein synthesis, suggesting the involvement of a genomic mechanism. The time course for 1,25-(OH) 2 D 3 induction of 24-hydroxylase mRNA levels paralleled the increase in synthesis of 24-hydroxylated polar metabolites, suggesting that, similar to kidney (15, 16) and intestine (17) , in normal PBM 1,25-(OH) 2 D 3 induces 25OHD 3 catabolism and its own degradation through enhancement of 24-hydroxylase gene transcription. In contrast, cytokine-activated macrophages exhibit no induction of 24-hydroxylase activity by either the excessive 1,25-(OH) 2 D 3 levels endogenously generated (11, 21) A role for the state of differentiation rather than VDR levels in the response to exogenous 1,25-(OH) 2 D 3 has been reported for the modulation of the expression of the osteocalcin (38) and 24-hydroxylase genes (39) in rat osteoblasts, the calcium binding protein in cells of the crypt and the villus of the intestine (40) , and for the induction of 24-hydroxylase in HT-29 human colon cancer cells (41) and murine keratinocytes (42) . In our studies, the difference in 1,25(OH) 2 D 3 induction of 24-hydroxylase mRNA levels between peripheral monocytes and pulmonary alveolar macrophages supports the findings that the transcriptional and/or translational steps may be more sensitive in less differentiated cells than in more highly differentiated (mature) ones (38 -42) .
We utilized phorbol-differentiated THP-1 cells to assess the effect of activation of human macrophages with the cytokine ␥-IFN, responsible for 1,25-(OH) 2 D 3 overproduction by PAM in sarcoidosis and tuberculosis (32, 33) , on the genomic response to 1,25-(OH) 2 This antagonism between ␥-IFN and 1,25-(OH) 2 D 3 is physiologically relevant as ␥-IFN also impairs 1,25-(OH) 2 D 3 induction of 24-hydroxylase mRNA levels in normal human monocytes.
24-hydroxylase is expressed in almost every vitamin Dresponsive tissue, which raises the possibility that the inhibitory effects of ␥-IFN on 1,25-(OH) 2 D 3 induction of 24-hydroxylase may not be restricted to monocytes and macrophages. ␥-IFN antagonism might extend to renal (15, 16) and intestinal (17) 24-hydroxylases, the major contributors to systemic 1,25-(OH) 2 D 3 inactivation. This notion is supported by the demonstration that, in patients with sarcoidosis, despite the supranormal serum concentrations of 1,25(OH) 2 D 3 , there is no increase in the metabolic clearance rate of 1,25-(OH) 2 D 3 (43) .
The presence of classical vitamin D responsive elements in the promoter region of the human 24-hydroxylase (44) suggests that the antagonistic effects of ␥-IFN may extend to other vitamin D-regulated genes. In fact, ␥-IFN and TNF␣ inhibit 1,25-(OH) 2 D 3 -induced osteocalcin gene transcription in rat osteoablasts (45, 46) . Both cytokines also induce the expression of the transcription factor AP-1, and it was proposed that cytokine inhibition of 1,25(OH) 2 D 3 -induced expression of osteocalcin was the result of the presence of an AP-1 DNA-binding site overlapping the VDR binding domain in the promoter region of the rat osteocalcin gene (38, 47) . This, however, cannot be the mechanism mediating the inhibitory effects of ␥-IFN on 1,25(OH) 2 D 3 -induction of 24-hydroxylase gene transcription. Although there is an AP-1 binding site in the human 24-hydroxylase promoter (44) , the induction of AP-1 activity with phorbol esters stimulates rather than inhibits 1,25-(OH) 2 D 3 transactivating function in kidney (18) and intestinal (19, 48) (49, 50) . There has been no further characterization of the mechanisms mediating the inhibitory effect of ␥-IFN on 1,25-(OH) 2 D 3 -induction of the rat osteocalcin gene, except for the demonstration that, unlike TNF␣, the effects of ␥-IFN require ongoing protein synthesis (45) .
In summary, the studies presented here illustrate that, in 
